Alcon announces fda approval of tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye disease

Geneva--(business wire)--alcon announces fda approval of tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye disease.
ALC Ratings Summary
ALC Quant Ranking